Abstract | BACKGROUND: In patients with atopic diseases, cationic-charged eosinophil proteins are deposited in inflamed tissues. Although the role of cytokines in cell activation is well established, the presence of cationic-charged tissue can also be an important factor in inflammatory cell function. OBJECTIVES: We sought to determine whether increased cationic charge seen in an atopic microenvironment plays a role in the activation of eosinophils. METHODS: RESULTS: CONCLUSION: Cationic-charged surfaces induce increased eosinophil mediator release by increasing the density of CD18 expression available at the target surface.
|
Authors | Darryl J Adamko, Yingqi Wu, Farnam Ajamian, Ramses Ilarraza, Redwan Moqbel, Gerald J Gleich |
Journal | The Journal of allergy and clinical immunology
(J Allergy Clin Immunol)
Vol. 122
Issue 2
Pg. 383-90, 390.e1-4
(Aug 2008)
ISSN: 1097-6825 [Electronic] United States |
PMID | 18455220
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Androstadienes
- CD18 Antigens
- Cations
- Cytokines
- Protein Kinase Inhibitors
- Receptors, Neuropeptide Y
- Stilbenes
- neuropeptide Y4 receptor
- 3,3',4,5'-tetrahydroxystilbene
- Heparin
- Dextran Sulfate
- Genistein
- Eosinophil Peroxidase
- Protein Kinases
- Eosinophil-Derived Neurotoxin
- Eosinophil Cationic Protein
- Wortmannin
|
Topics |
- Androstadienes
(pharmacology)
- CD18 Antigens
(metabolism)
- Cations
- Cell Adhesion
- Cell Degranulation
- Cell Polarity
- Cytokines
(immunology)
- Dextran Sulfate
(pharmacology)
- Eosinophil Cationic Protein
(metabolism)
- Eosinophil Peroxidase
(metabolism)
- Eosinophil-Derived Neurotoxin
(metabolism)
- Eosinophils
(drug effects, immunology, metabolism)
- Genistein
(pharmacology)
- Heparin
(pharmacology)
- Humans
- Protein Kinase Inhibitors
(pharmacology)
- Protein Kinases
(metabolism)
- Receptors, Neuropeptide Y
(metabolism)
- Signal Transduction
- Stilbenes
(pharmacology)
- Wortmannin
|